Digital Pathology Transformation in a Supraregional Germ Cell Tumour Network

Diagnostics

卷:11

Nikki Mercer¹  Harry R. Haynes¹  Andrea Taibi²  Derek Roskell³  Anthony Sackville³  Darrin Siiankoski³  Judith Craft³  Sharon Roberts-Gant³  Lisa Browning³  Gabrielle Rees³  Helen Hemsworth³  Kieron White³  Maria Soares³  Ian S. D. Roberts³  Joao Reis³  Jim Davies⁴  Andrew Protheroe⁵  Jens Rittscher⁶  Richard Colling⁷  Clare Verrill⁷  Mark Tuthill⁸  Angus Molyneux⁹  Niveen Abdullah⁹  Elizabeth Johnson⁹  Ruth Macpherson¹⁰  Zoe Traill¹⁰  Jacqueline Redgwell¹¹  Mark Sullivan¹¹ 

[1] Department of Cellular Pathology, Great Western Hospitals NHS Foundation Trust, Swindon SN3 6BB, UK;

[2] Department of Cellular Pathology, North Bristol NHS Trust, Bristol BS10 5NB, UK;

[3] Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK;

[4] Department of Computer Science, University of Oxford, Oxford OX1 2JD, UK;

[5] Department of Oncology, University of Oxford, Oxford OX3 9DU, UK;

[6] Institute of Biomedical Engineering, University of Oxford, Oxford OX3 7DQ, UK;

[7] Nuffield Department of Surgical Sciences, University of Oxford, Oxford OX3 9DU, UK;

[8] Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK;

[9] Pathology Department, Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes MK6 5DL, UK;

[10] Radiology Department, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK;

[11] Urology Department, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK;

关键词: digital;    pathology;    testis;    germ cell;   

DOI  :  10.3390/diagnostics11122191

来源: DOAJ

【 摘 要 】

Background: In this article we share our experience of creating a digital pathology (DP) supraregional germ cell tumour service, including full digitisation of the central laboratory. Methods: DP infrastructure (Philips) was deployed across our hospital network to allow full central digitisation with partial digitisation of two peripheral sites in the supraregional testis germ cell tumour network. We used a survey-based approach to capture the quantitative and qualitative experiences of the multidisciplinary teams involved. Results: The deployment enabled case sharing for the purposes of diagnostic reporting, second opinion, and supraregional review. DP was seen as a positive step forward for the departments involved, and for the wider germ cell tumour network, and was completed without significant issues. Whilst there were challenges, the transition to DP was regarded as worthwhile, and examples of benefits to patients are already recognised. Conclusion: Pathology networks, including highly specialised services, such as in this study, are ideally suited to be digitised. We highlight many of the benefits but also the challenges that must be overcome for such clinical transformation. Overall, from the survey, the change was seen as universally positive for our service and highlights the importance of engagement of the whole team to achieve success.

【 授权许可】

Unknown